These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of Pneumocystis carinii pneumonia in patients with AIDS. Wordell CJ, Hauptman SP. Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063 [Abstract] [Full Text] [Related]
3. Update on pentamidine for the treatment of Pneumocystis carinii pneumonia. Salamone FR, Cunha BA. Clin Pharm; 1988 Jul; 7(7):501-10. PubMed ID: 3046830 [Abstract] [Full Text] [Related]
4. Adverse effects associated with intravenous pentamidine isethionate as treatment of Pneumocystis carinii pneumonia in AIDS patients. Balslev U, Nielsen TL. Dan Med Bull; 1992 Aug; 39(4):366-8. PubMed ID: 1526188 [Abstract] [Full Text] [Related]
5. Treatment of Pneumocystis carinii pneumonitis with trimethoprim-sulfamethoxazole. Hughes WT, Feldman S, Sanyal SK. Can Med Assoc J; 1975 Jun 14; 112(13 Spec No):47-50. PubMed ID: 1079469 [Abstract] [Full Text] [Related]
6. The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Small CB, Harris CA, Friedland GH, Klein RS. Arch Intern Med; 1985 May 14; 145(5):837-40. PubMed ID: 3873229 [Abstract] [Full Text] [Related]
7. Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: pathophysiology, therapy, and prevention. Montgomery AB. Semin Respir Infect; 1989 Jun 14; 4(2):102-10. PubMed ID: 2664934 [Abstract] [Full Text] [Related]
8. [Pentamidine inhalation for Pneumocystis carinii pneumonia in AIDS]. Pines A, Giladi M, Moshkowitz M, Finkelstein A, Levo Y. Harefuah; 1989 Mar 15; 116(6):311-2. PubMed ID: 2786489 [Abstract] [Full Text] [Related]
9. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia. Warnock AC, Rimland D. Pharmacotherapy; 1996 Mar 15; 16(6):1030-8. PubMed ID: 8947975 [Abstract] [Full Text] [Related]
11. Treatment of Pneumocystis carinii pneumonitis. A comparative trial of sulfamethoxazole-trimethoprim v pentamidine in pediatric patients with cancer: report from the Children's Cancer Study Group. Siegel SE, Wolff LJ, Baehner RL, Hammond D. Am J Dis Child; 1984 Nov 15; 138(11):1051-4. PubMed ID: 6388315 [Abstract] [Full Text] [Related]
12. Cost-effectiveness models of clinical trials of new pharmaceuticals for AIDS-related Pneumocystis carinii pneumonia: are they helpful to policy makers? Bennett CL, Oddone E, Matchar D. Clin Perform Qual Health Care; 1995 Nov 15; 3(3):156-64. PubMed ID: 10151167 [Abstract] [Full Text] [Related]
13. Atovaquone: a new antipneumocystis agent. Artymowicz RJ, James VE. Clin Pharm; 1993 Aug 15; 12(8):563-70. PubMed ID: 8222520 [Abstract] [Full Text] [Related]
17. Treatment and prophylaxis of Pneumocystis carinii pneumonia. Masur H, Kovacs JA. Infect Dis Clin North Am; 1988 Jun 15; 2(2):419-28. PubMed ID: 3060526 [Abstract] [Full Text] [Related]
18. Advances in the treatment and prophylaxis of Pneumocystis carinii pneumonia. Warren E, George S, You J, Kazanjian P. Pharmacotherapy; 1997 Jun 15; 17(5):900-16. PubMed ID: 9324180 [Abstract] [Full Text] [Related]